The latest issue of Chemistry Today explores the renaissance and industrial evolution of peptide and oligonucleotide therapeutics. It covers process development, Industry 5.0 laboratories, the Critical Medicines Act, data maturity, investment strategies, siRNA discovery, novel manufacturing approaches, and features IOPC 2026 proceedings focused on peptide and oligonucleotide innovation.
Help us provide you with the most customized service possible by filling out the form below
Your personal data
Please login to view your profile.
LISTEN TO OUR PODCAST
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
PANEL DISCUSSION ON
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.
Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.